Business
Labwire Announces Corporate Updates and Strategic Initiatives for 2023 Year-End and 2024 Outlook
Labwire Announces Corporate Updates and Strategic Initiatives for 2023 Year-End and 2024 Outlook.
About this update from Labwire, Inc.
[{"type":"text","content":"FOR IMMEDIATE RELEASELabwire Announces Corporate Updates and Strategic Initiatives for 2023 Year-End and 2024 OutlookPHOENIX, Arizona, December 28th, 2023 (OTC Markets) - Labwire, Inc. (OTC: LBWR), a forward-thinking player in the digital marketing landscape, is pleased to share significant corporate updates and strategic initiatives as the company approaches the close of the fiscal year 2023 and sets the stage for an ambitious 2024.Super 99 Center PerformanceSuper 99 Center, a flagship retail entity under Labwire, is poised to close the year 2023 with approximately $1,600,000 in net sales, excluding ancillary incomes such as lottery sales, which generated an additional $150,000. The company plans to continue its expansion strategy, identifying lucrative opportunities with favorable lease terms for additional locations.A groundbreaking model underpinning Super 99 Center's expansion is the projection that each $200,000 investment will yield $500,000 in sales within the first year, breaking even within a swift 18-month timeframe.Call Affiliate SubsidiaryLabwire's recent acquisition of Call Affiliate, a pay-per-call affiliate marketing powerhouse, has proven to be a strategic triumph. The subsidiary, established in Q4, has already commenced revenue generation in December, operating across various verticals.The scalability of Call Affiliate is noteworthy, as it requires minimal capital expenditure. The subsidiary has strategically aligned itself with brand companies in the consumer services and products sector, collaborating directly with them to drive lead generation and revenue growth.The incorporation of both SEO efforts and organic traffic into the marketing strategy positions Call Affiliate for sustained success in its lead generation endeavors.Parent Level Corporate ActionIn anticipation of an expected decrease in the federal interest rate in early to mid-next year, Labwire has deliberately postponed capital financing to explore more favorable options. Since the acquisition of Super 99 Center earlier this year, Labwire has refrained from issuing additional stock, maintaining a total share outstanding at 179 million shares.Imperium Partners, under the control of CEO Shin Hwang, has been instrumental in funding the company's operating expenses and is poised to continue supporting Labwire in the coming year. As of yesterday, Dece...